148 related articles for article (PubMed ID: 7003045)
21. [The bioavailability of orally administered drugs with special regard to the liver as a filter for foreign matter].
Raaflaub J
Schweiz Med Wochenschr; 1980 Mar; 110(10):354-62. PubMed ID: 7394464
[TBL] [Abstract][Full Text] [Related]
22. Methods for estimating drug bioavailability parameters. Part 3: Peculiarities of pharmacokinetic analysis in assessment of bioavailability.
Firsov AA; Piotrovskii VK
Pharmazie; 1986 Jul; 41(7):457-65. PubMed ID: 3534896
[No Abstract] [Full Text] [Related]
23. [Quality care in meat production. 'From Von Ostertag to total quality care'].
van Logtestijn JG
Tijdschr Diergeneeskd; 1994 Feb; 119(4):93-8. PubMed ID: 8122220
[TBL] [Abstract][Full Text] [Related]
24. [Effects of drug distribution, entero-hepatic cycle, bioavailability].
Bailly-Salins F; Woronoff-Lemsi MC
Soins; 1998 Apr; (624):41-3. PubMed ID: 9633463
[No Abstract] [Full Text] [Related]
25. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
26. Drug residues in food-producing animals.
J Environ Pathol Toxicol; 1980; 3(5-6):1-147. PubMed ID: 7441075
[No Abstract] [Full Text] [Related]
27. [Effect of nutrition on drug bioavailability].
Boutin-Pannetier MS; Delhotal-Landes B; Flouvat B
Therapie; 1986; 41(5):397-402. PubMed ID: 3544322
[No Abstract] [Full Text] [Related]
28. [First-pass effect as a therapeutic problem].
Danek A
Pol Tyg Lek; 1983 Apr; 38(16):511-4. PubMed ID: 6634498
[No Abstract] [Full Text] [Related]
29. The utility of cyclodextrins for enhancing oral bioavailability.
Carrier RL; Miller LA; Ahmed I
J Control Release; 2007 Nov; 123(2):78-99. PubMed ID: 17888540
[TBL] [Abstract][Full Text] [Related]
30. Methods for estimating drug bioavailability parameters. Part 1: Concept of biological availability and methods for estimating the extent of systemic absorption.
Firsov AA; Piotrovskii VK
Pharmazie; 1986 May; 41(5):313-9. PubMed ID: 3737660
[No Abstract] [Full Text] [Related]
31. [Drug metabolism in the small intestine--the significance for biological availability].
Andersen VC; Sonne J
Ugeskr Laeger; 2000 May; 162(22):3215-9. PubMed ID: 10850220
[TBL] [Abstract][Full Text] [Related]
32. First-pass metabolism.
Brodie MJ
Practitioner; 1983 Oct; 227(1384):1619-27. PubMed ID: 6634632
[No Abstract] [Full Text] [Related]
33. Cumulative risk assessment of pesticide residues in food.
Boobis AR; Ossendorp BC; Banasiak U; Hamey PY; Sebestyen I; Moretto A
Toxicol Lett; 2008 Aug; 180(2):137-50. PubMed ID: 18585444
[TBL] [Abstract][Full Text] [Related]
34. The toxicological evaluation of drug residues.
Morton DM
J Environ Pathol Toxicol; 1980; 3(5-6):65-72. PubMed ID: 7441101
[No Abstract] [Full Text] [Related]
35. Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique.
von Richter O; Greiner B; Fromm MF; Fraser R; Omari T; Barclay ML; Dent J; Somogyi AA; Eichelbaum M
Clin Pharmacol Ther; 2001 Sep; 70(3):217-27. PubMed ID: 11557909
[TBL] [Abstract][Full Text] [Related]
36. Effect of sodium [36Cl]chlorate dose on total radioactive residues and residues of parent chlorate in beef cattle.
Smith DJ; Oliver CE; Caton JS; Anderson RC
J Agric Food Chem; 2005 Sep; 53(18):7352-60. PubMed ID: 16131153
[TBL] [Abstract][Full Text] [Related]
37. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
38. What is bioavailability? Philosophy of bioavailability testing.
Ritschel WA
Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):777-86. PubMed ID: 6530912
[TBL] [Abstract][Full Text] [Related]
39. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.
Prueksaritanont T; Gorham LM; Ellis JD; Fernandez-Metzler C; Deluna P; Gehret JR; Strong KL; Hochman JH; Askew BC; Duggan ME; Gilbert JD; Lin JH; Vyas KP
Drug Metab Dispos; 1996 Nov; 24(11):1263-71. PubMed ID: 8937862
[TBL] [Abstract][Full Text] [Related]
40. Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.
Vishwanathan K; Babalola K; Wang J; Espina R; Yu L; Adedoyin A; Talaat R; Mutlib A; Scatina J
Chem Res Toxicol; 2009 Feb; 22(2):311-22. PubMed ID: 19067650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
